World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
271 Biosyent, Inc. $93.7 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
272 Maywufa Company Ltd $92.9 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
273 Vistin Pharma ASA $91.5 M

(July 1, 2024)

 Norway Norway Healthcare Norway Drug Manufacturers—Specialty & Generic
274 Harborside, Inc. $86.2 M

(Sept. 1, 2022)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
275 Vita Life Sciences Limited $81.9 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
276 Theratechnologies Inc. $81.5 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
277 Assertio Holdings, Inc. $80.5 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
278 Sakar Healthcare Ltd $80.2 M India Indian Healthcare Indian Drug Manufacturers—Specialty & Generic
279 HLS Therapeutics Inc. $78.5 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
280 Oasmia Pharmaceutical AB $76.7 M

(June 1, 2022)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
281 TSH Biopharm Corp Ltd $75.1 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
282 Golden Biotechnology Corp $74.1 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
283 SymBio Pharmaceuticals Ltd $71.9 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
284 Green Organic Dutchman Holdings Ltd. $71.7 M

(Sept. 1, 2021)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
285 Endo International plc $68.8 M

(Oct. 1, 2022)

 Ireland Irish Healthcare Irish Drug Manufacturers—Specialty & Generic
286 FUREN Group Pharmaceutical Co. Ltd $66.6 M

(June 1, 2023)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
287 Orexo AB $66.0 M

(July 1, 2024)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
288 OptiNose, Inc. $65.9 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
289 Jushi Holdings, Inc. $65.7 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
290 GeneFerm Biotechnology Co. Ltd $63.4 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
291 Solasia Pharma K.K. $62.5 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
292 Next Green Wave Holdings, Inc. $61.4 M

(March 1, 2022)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
293 InterCure Ltd $60.9 M Israel Israeli Healthcare Israeli Drug Manufacturers—Specialty & Generic
294 The Valens Company Inc. $60.7 M

(Jan. 1, 2023)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
295 Shedir Pharma Group S.p.A. $57.7 M Italy Italian Healthcare Italian Drug Manufacturers—Specialty & Generic
296 Venture Life Group plc $57.6 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
297 InnoPharmax, Inc. $56.5 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
298 LIWANLI Innovation Co. Ltd $56.3 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
299 Fusen Pharmaceutical Company Ltd $56.1 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
300 Icanic Brands Co, Inc. $54.1 M

(Feb. 1, 2023)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2025

271. Biosyent, Inc.

Company Profile: Biosyent, Inc.
Market Cap (USD): $93.7 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

272. Maywufa Company Ltd

Company Profile: Maywufa Company Ltd
Market Cap (USD): $92.9 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

273. Vistin Pharma ASA

Company Profile: Vistin Pharma ASA
Market Cap (USD): $91.5 M (July 1, 2024)
Country: Norway
Sector: Norway Healthcare
Industry: Norway Drug Manufacturers—Specialty & Generic

274. Harborside, Inc.

Company Profile: Harborside, Inc.
Market Cap (USD): $86.2 M (Sept. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

275. Vita Life Sciences Limited

Company Profile: Vita Life Sciences Limited
Market Cap (USD): $81.9 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

276. Theratechnologies Inc.

Company Profile: Theratechnologies Inc.
Market Cap (USD): $81.5 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

277. Assertio Holdings, Inc.

Company Profile: Assertio Holdings, Inc.
Market Cap (USD): $80.5 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

278. Sakar Healthcare Ltd

Company Profile: Sakar Healthcare Ltd
Market Cap (USD): $80.2 M
Country: India
Sector: Indian Healthcare
Industry: Indian Drug Manufacturers—Specialty & Generic

279. HLS Therapeutics Inc.

Company Profile: HLS Therapeutics Inc.
Market Cap (USD): $78.5 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

280. Oasmia Pharmaceutical AB

Company Profile: Oasmia Pharmaceutical AB
Market Cap (USD): $76.7 M (June 1, 2022)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

281. TSH Biopharm Corp Ltd

Company Profile: TSH Biopharm Corp Ltd
Market Cap (USD): $75.1 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

282. Golden Biotechnology Corp

Company Profile: Golden Biotechnology Corp
Market Cap (USD): $74.1 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

283. SymBio Pharmaceuticals Ltd

Company Profile: SymBio Pharmaceuticals Ltd
Market Cap (USD): $71.9 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

284. Green Organic Dutchman Holdings Ltd.

Company Profile: Green Organic Dutchman Holdings Ltd.
Market Cap (USD): $71.7 M (Sept. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

285. Endo International plc

Company Profile: Endo International plc
Market Cap (USD): $68.8 M (Oct. 1, 2022)
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Drug Manufacturers—Specialty & Generic

286. FUREN Group Pharmaceutical Co. Ltd

Company Profile: FUREN Group Pharmaceutical Co. Ltd
Market Cap (USD): $66.6 M (June 1, 2023)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

287. Orexo AB

Company Profile: Orexo AB
Market Cap (USD): $66.0 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

288. OptiNose, Inc.

Company Profile: OptiNose, Inc.
Market Cap (USD): $65.9 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

289. Jushi Holdings, Inc.

Company Profile: Jushi Holdings, Inc.
Market Cap (USD): $65.7 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

290. GeneFerm Biotechnology Co. Ltd

Company Profile: GeneFerm Biotechnology Co. Ltd
Market Cap (USD): $63.4 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

291. Solasia Pharma K.K.

Company Profile: Solasia Pharma K.K.
Market Cap (USD): $62.5 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

292. Next Green Wave Holdings, Inc.

Company Profile: Next Green Wave Holdings, Inc.
Market Cap (USD): $61.4 M (March 1, 2022)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

293. InterCure Ltd

Company Profile: InterCure Ltd
Market Cap (USD): $60.9 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Drug Manufacturers—Specialty & Generic

294. The Valens Company Inc.

Company Profile: The Valens Company Inc.
Market Cap (USD): $60.7 M (Jan. 1, 2023)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

295. Shedir Pharma Group S.p.A.

Company Profile: Shedir Pharma Group S.p.A.
Market Cap (USD): $57.7 M
Country: Italy
Sector: Italian Healthcare
Industry: Italian Drug Manufacturers—Specialty & Generic

296. Venture Life Group plc

Company Profile: Venture Life Group plc
Market Cap (USD): $57.6 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

297. InnoPharmax, Inc.

Company Profile: InnoPharmax, Inc.
Market Cap (USD): $56.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

298. LIWANLI Innovation Co. Ltd

Company Profile: LIWANLI Innovation Co. Ltd
Market Cap (USD): $56.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

299. Fusen Pharmaceutical Company Ltd

Company Profile: Fusen Pharmaceutical Company Ltd
Market Cap (USD): $56.1 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

300. Icanic Brands Co, Inc.

Company Profile: Icanic Brands Co, Inc.
Market Cap (USD): $54.1 M (Feb. 1, 2023)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

Top 1-year algo backtest: +327.04% - Try Disfold DeepFinance for FREE now!

Stay in touch